Narcan intranasal naloxone regulatory update

Adapt submitted an NDA to FDA for Narcan naloxone nasal spray to treat opioid overdose. The opioid antagonist nasal spray has Fast Track designation in the U.S. Adapt has worldwide rights to develop ...